Talis Biomedical (Talis Biomedical) Price-to-Tangible-Book : 0.24 (As of May. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Talis Biomedical Price-to-Tangible-Book?

As of today (2024-05-05), Talis Biomedical's share price is $9.15. Talis Biomedical's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $37.93. Hence, Talis Biomedical's Price to Tangible Book Ratio of today is 0.24.

The historical rank and industry rank for Talis Biomedical's Price-to-Tangible-Book or its related term are showing as below:

TLIS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.09 Med: 0.2 Max: 0.45
Current: 0.24

During the past 6 years, Talis Biomedical's highest Price to Tangible Book Ratio was 0.45. The lowest was 0.09. And the median was 0.20.

TLIS's Price-to-Tangible-Book is ranked better than
98.86% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 2.7 vs TLIS: 0.24

A closely related ratio is called PB Ratio. As of today, Talis Biomedical's share price is $9.15. Talis Biomedical's Book Value per Sharefor the quarter that ended in Dec. 2023 was $37.93. Hence, Talis Biomedical's P/B Ratio of today is 0.24.

Talis Biomedical Price-to-Tangible-Book Historical Data

The historical data trend for Talis Biomedical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talis Biomedical Price-to-Tangible-Book Chart

Talis Biomedical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

0.45

0.09

0.20

Talis Biomedical Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial														0.09	0.12	0.14	0.13	0.20

Competitive Comparison of Talis Biomedical's Price-to-Tangible-Book

For the Medical Devices subindustry, Talis Biomedical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Talis Biomedical's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Talis Biomedical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Talis Biomedical's Price-to-Tangible-Book falls into.

Talis Biomedical Price-to-Tangible-Book Calculation

Talis Biomedical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	9.15	/	37.933
	=	0.24

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Talis Biomedical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Talis Biomedical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Talis Biomedical (Talis Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Talis Biomedical Corp (NAS:TLIS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

3400 Bridge Parkway, Redwood City, CA, USA, 94065

Website

https://talisbio.com

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

Executives

Andrew A Lukowiak	officer: President, other: Chief Scientific Officer	1639 WINDEMERE DRIVE, SAN MARCOS CA 92078
Heinrich Dreismann	director	320 WAKARA WAY, SALT LAKE CITY UT 84108
Rebecca Markovich	officer: Interim CFO	CARS.COM INC., 300 S. RIVERSIDE PLAZA, SUITE 1000, CHICAGO IL 60606
Raymond Cheong	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Felix Baker	director, 10 percent owner	BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014
Baker Bros. Advisors Lp	director, 10 percent owner	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Julian Baker	director, 10 percent owner	BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014
Baker Bros. Advisors (gp) Llc	director, 10 percent owner	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Baker Brothers Life Sciences Lp	director, 10 percent owner	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
L.p. 667,	director, 10 percent owner	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Brian J Blaser	director, officer: President and CEO	561 CIRCLE LANE, LAKE FOREST IL 60045
Ramesh Ramakrishnan	officer: Sr. Vice President, R&D	230 CONSTITUTION DRIVE, MENLO PARK CA 94025
Randal W Scott	director	171 MAIN STREET #225, LOS ALTOS CA 94022
Jeryl L Hilleman	director	C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Kimberly J Popovits	director	301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063